Notice of General Meeting/Proxy Form
Released
Released
Announcement PDF
ACN 061 503 375
NOTICE OF GENERAL MEETING
10 December 2025 COMMENCING 11 am (Adelaide Time, ACDT)
Held at the Terrace Hotel, 208 South Terrace, Adelaide South Australia
If you are unable to attend the Meeting, please complete your proxy form and return it in accordance with the
instructions set out on that form.
Page | 1
Voting Exclusion Statement
The Company will disregard any votes cast in favour on Resolution 1 by or on behalf of a person who participated
in the issue of the Placement Shares and any associate of that person of those persons. However this does not
apply to a vote cast in favour of a resolution by:
(a) a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with the
directions given to the proxy or attorney to vote on the resolution in that way; or
(b) the chair of the Meeting as proxy or attorney for a person who is entitled to vote on the resolution, in
accordance with a direction given to the chair to vote on the resolution as the chair decides; or
(c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a
beneficiary provided the following conditions are met:
i. the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded
from voting and is not an associate of a person excluded from voting on the resolution; and
ii. the Shareholder votes on the resolution in accordance with the directions given by the beneficiary
to the Shareholder to vote in that way
Voting Exclusion Statement
The Company will disregard any votes cast in favour on Resolution 2 by or on behalf of a person who is expected
to participate in, or who will obtain a material benefit as a result of, the proposed issue of the Placement Options
(except a benefit solely by reason of being a Shareholder) and any associate of those persons. However this does
not apply to a vote cast in favour of a resolution by:
(a) a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with the
directions given to the proxy or attorney to vote on the resolution in that way; or
(b) the chair of the Meeting as proxy or attorney for a person who is entitled to vote on the resolution, in
accordance with a direction given to the chair to vote on the resolution as the chair decides; or
(c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a
beneficiary provided the following conditions are met:
i. the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded
from voting and is not an associate of a person excluded from voting on the resolution; and
ii. the Shareholder votes on the resolution in accordance with the directions given by the beneficiary
to the Shareholder to vote in that way
NOTICE OF GENERAL MEETING
ORDINARY BUSINESS
Resolution 1 - Ratification of Issue of Placement Shares
To consider, and if thought fit, pass the following resolution as an ordinary resolution:
“That for the purposes of ASX Listing Rule 7.4 and for all other purposes, Shareholders ratify and approve the
issue by the Company of 742,857,143 Placement Shares on or about 24 October 2025 at an issue price of
$0.0175 per share made under the Company’s Listing Rule 7.1 and 7.1A placement capacity, on the terms and
conditions set out in the Explanatory Memorandum.”
Resolution 2 – Approval of Issue of the Placement Options
To consider, and if thought fit, pass the following resolution as an ordinary resolution:
“That for the purposes of ASX Listing Rule 7.1 and for all other purposes, Shareholders approve the issue by the
Company of 458,714,286 Placement Options as part of the Placement, on the terms and conditions set out in
the Explanatory Memorandum.”
Resolution 3 – Approval of Issue of the SPP Options
To consider, and if thought fit, pass the following resolution as an ordinary resolution:
Page | 2
Voting Exclusion Statement
The Company will disregard any votes cast in favour on Resolution 3 by or on behalf of a person who is expected
to participate in, or who will obtain a material benefit as a result of, the proposed issue of the Placement Options
(except a benefit solely by reason of being a Shareholder) and any associate of those persons. However this does
not apply to a vote cast in favour of a resolution by:
(a) a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with the
directions given to the proxy or attorney to vote on the resolution in that way; or
(b) the chair of the Meeting as proxy or attorney for a person who is entitled to vote on the resolution, in
accordance with a direction given to the chair to vote on the resolution as the chair decides; or
(c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a
beneficiary provided the following conditions are met:
i. the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded
from voting and is not an associate of a person excluded from voting on the resolution; and
ii. the Shareholder votes on the resolution in accordance with the directions given by the beneficiary
to the Shareholder to vote in that way
Voting Exclusion Statement
The Company will disregard any votes cast in favour on Resolution 4 by or on behalf of Bell Potter, Canaccord
Genuity or their nominees and any person who is expected to participate in, or who will obtain a material benefit
as a result of, the proposed issue of the Broker Options (except a benefit solely by reason of being a Shareholder)
and any associate of those persons. However this does not apply to a vote cast in favour of a resolution by:
(a) a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with the
directions given to the proxy or attorney to vote on the resolution in that way; or
(b) the chair of the Meeting as proxy or attorney for a person who is entitled to vote on the resolution, in
accordance with a direction given to the chair to vote on the resolution as the chair decides; or
(c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a
beneficiary provided the following conditions are met:
i. the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded
from voting and is not an associate of a person excluded from voting on the resolution; and
ii. the Shareholder votes on the resolution in accordance with the directions given by the beneficiary
to the Shareholder to vote in that way
Voting Exclusion Statement
The Company will disregard any votes cast in favour on Resolution 5 by or on behalf of Mr Jean-Dominique Sorel
or his nominees and any associate of those persons. However this does not apply to a vote cast in favour of a
resolution by:
(a) a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with the
directions given to the proxy or attorney to vote on the resolution in that way; or
“That for the purposes of ASX Listing Rule 7.1 and for all other purposes, Shareholders approve the issue by the
Company of up to 687,001,753 SPP Options as part of the Security Purchase Plan, on the terms and conditions
set out in the Explanatory Memorandum.”
Resolution 4 – Approval of Issue of Broker Options as part of fees for Joint Lead Managers
To consider, and if thought fit, pass the following resolution as an ordinary resolution:
“That for the purposes of ASX Listing Rule 7.1 and for all other purposes, Shareholders approve the issue by the
Company of 13 million Options as part of the fees payable to the Joint Lead Managers to the Placement, on the
terms and conditions set out in the Explanatory Memorandum.”
Resolution 5 – Approval for Jean-Dominique Sorel participation in Placement
To consider, and if thought fit, pass the following resolution as an ordinary resolution:
"That, for the purposes of Listing Rule 10.11 and all other purposes, approval is given for the Company to issue
up to 1,714,285 Shares and 1,028,571 Options to Mr Jean-Dominique Sorel (or his nominees) on the terms and
conditions set out in the Explanatory Memorandum.'
Page | 3
Voting Exclusion Statement
The Company will disregard any votes cast in favour on Resolution 6 by or on behalf of Ms Sue-Ann Higgins or her
nominees and any associate of those persons. However this does not apply to a vote cast in favour of a resolution
by:
(a) a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with the
directions given to the proxy or attorney to vote on the resolution in that way; or
(b) the chair of the Meeting as proxy or attorney for a person who is entitled to vote on the resolution, in
accordance with a direction given to the chair to vote on the resolution as the chair decides; or
(c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a
beneficiary provided the following conditions are met:
i. the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded
from voting and is not an associate of a person excluded from voting on the resolution; and
ii. the Shareholder votes on the resolution in accordance with the directions given by the beneficiary
to the Shareholder to vote in that way
Resolution 6 – Approval to issue SPP Options to Sue-Ann Higgins
To consider, and if thought fit, pass the following resolution as an ordinary resolution:
"That, for the purposes of Listing Rule 10.11 and for all other purposes, shareholders approve the issue of up to 34,285
SPP Options to Ms Sue-Ann Higgins (or her nominees) on the terms and conditions set out in the Explanatory
Memorandum."
By Order of the Board
Sarah Clarke
Company Secretary
Dated this 30th day of October 2025
(b) the chair of the Meeting as proxy or attorney for a person who is entitled to vote on the resolution, in
accordance with a direction given to the chair to vote on the resolution as the chair decides; or
(c) a Shareholder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a
beneficiary provided the following conditions are met:
i. the beneficiary provides written confirmation to the Shareholder that the beneficiary is not excluded
from voting and is not an associate of a person excluded from voting on the resolution; and
ii. the Shareholder votes on the resolution in accordance with the directions given by the beneficiary
to the Shareholder to vote in that way
Page | 4
Voting Entitlements
For the purposes of ascertaining the voting entitlements for the General Meeting, the shareholding of each
Shareholder will be as it appears in the share register on 8 December 2025 at 6.30 pm (Adelaide time ACDT).
Proxies
A Shareholder entitled to attend and vote at the Meeting has the right to appoint a proxy, who need not be a
Shareholder of the Company. If a Shareholder is entitled to cast two or more votes they may appoint two proxies
and may specify the percentage of votes each proxy is appointed to exercise.
The Proxy Form must be deposited at the share registry of the Company, Computershare Investor Services Pty
Limited, located at GPO Box 242, Melbourne VIC 3001, or
by facsimile to Computershare on 1800 783 447 (within Australia) or +61 3 9473 2555 (outside Australia), or
by casting a vote online by visiting www.investorvote.com.au and by entering the Control Number, SRN/HIN and
postcode, which are shown on the first page of the Proxy Form not later than 48 hours before the commencement
of the Meeting.
For Intermediary Online subscribers only (custodians), please visit www.intermediaryonline.com to submit your
voting intentions, which must be submitted by not later than 48 hours before the commencement of the Meeting.
Corporate Representative
A corporation that is a Shareholder or a proxy may elect to appoint a person to act as its corporate representative
at the meeting, in which case the corporate Shareholder or proxy (as applicable) must provide that person with a
certificate or letter executed in accordance with the Corporations Act authorising him or her to act as that
Shareholder’s or proxy’s (as applicable) corporate representative. The authority must be sent to the Company
and/or the Company’s Share Registry (detailed above) in advance of the meeting or handed in at the Meeting when
registering as a corporate representative.
Explanatory Memorandum
The Explanatory Memorandum accompanying this Notice of General Meeting is incorporated in and comprises
part of this Notice of General Meeting and should be read in conjunction with this Notice.
Page | 5
EXPLANATORY MEMORANDUM
This Explanatory Memorandum has been prepared to assist Shareholders in consideration of resolutions proposed for a
General Meeting of the Company to be held on 30 June 2025 commencing at 11am (Adelaide time ACDT). The venue for the
meeting is the Terrace Hotel, 208 South Terrace, Adelaide South Australia.
It should be read in conjunction with the accompanying Notice of General Meeting.
Resolution 1 – Ratification of Issue of Placement Shares
Background
On 17 October 2025, the Company announced a strongly supported $13 million Placement to institutional and
professional/sophisticated investors, to be followed by a Security Purchase Plan (SPP) to raise funds to progress the Great
White Project, the HPA project and for general working capital (including costs of the capital raise).
On 24 October 2025 the Company issued 742,857,143 Placement Shares pursuant to its capacity under Listing Rule 7.1 and
Listing Rule 7.1A (Placement Shares).
The purpose of Resolution 1 is to seek Shareholder approval and ratification of the issue of the Placement Shares undertaken
without Shareholder approval pursuant to Listing Rule 7.1 in October 2025.
Regulatory Requirements
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of equity securities that a listed
company can issue without approval of its shareholders over any 12-month period to 15% of the fully-paid ordinary securities
it had on issue at the start of that period.
Under Listing Rule 7.1A, an eligible entity can seek approval from its members, by way of a special resolution passed at its
annual general meeting, to increase this 15% limit by an extra 10%, to 25%.
The Placement Shares did not fit within any of the exceptions to Listing Rule 7.1 and, as it has not yet been approved by the
Company’s Shareholders, it effectively uses up part of the 15% limit in Listing Rule 7.1 and the Company's additional limit
under Listing Rule 7.1A, reducing the Company’s capacity to issue further Equity Securities without Shareholder approval
under Listing Rules 7.1 and 7.1A for the 12-month period following the issue date.
Listing Rule 7.4 allows the shareholders of a listed company to approve an issue of Equity Securities after it has been made
or agreed to be made. If they do, the issue is taken to have been approved under Listing Rule 7.1 and Listing Rule 7.1A and
so does not reduce the Company’s capacity to issue further Equity Securities without Shareholder approval under that rule.
The Company wishes to retain as much flexibility as possible to issue additional Equity Securities into the future without
having to obtain Shareholder approval for such issues under Listing Rules 7.1 and 7.1A. To this end, Resolution 1 seeks
shareholder approval to the Placement Shares under and for the purposes of Listing Rule 7.4.
If Resolution 1 is passed, the Placement Shares will be excluded in calculating the Company’s 15% limit in Listing Rule 7.1 and
10% limit in Listing Rule 7.1A, effectively increasing the number of Equity Securities it can issue without shareholder approval
over the 12-month period following the issue date.
If Resolution 1 is not passed, the Placement Shares will be included in calculating the Company’s 15% limit in Listing Rule 7.1
and 10% limit in Listing Rule 7.1A, effectively decreasing the number of Equity Securities it can issue without shareholder
approval over the 12-month period following the issue date.
Listing Rules Information Requirements
In accordance with the requirements of Listing Rule 7.5, the following information is provided in relation to Resolution 1:
i. The Placement Shares were issued to various institutional and professional/sophisticated investors (being investors
identified by the Joint Lead Managers or existing Shareholders and excluding any related parties, members of Key
Management Personnel, substantial Shareholders or advisers), other than the participation of Mr Jean-Dominique
Sorel, subject to approval of Resolution 5.
i. The Company issued a total of 742,857,143 Placement Shares under the Placement using its placement capacity
under Listing Rules 7.1 and 7.1A (with 361,189,503 Placement Shares coming under Listing Rule 7.1 and 381,667,640
Placement Shares coming within Listing Rule 7.1A).
ii. The Placement Shares are fully-paid ordinary shares in the Company and rank equally with all other Shares on issue.
iii. The Placement Shares were issued on 24 October 2025.
iv. The Placement Shares were issued at a price of $0.0175 per share.
Page | 6
v. As announced to the ASX on 17 October 2025, the funds raised are intended to be applied towards the development
of the Great White Project and advancement of HPA, including early works, equipment procurement, product
marketing (including HPA), general working capital and costs of the capital raise.
vi. The key terms of the Placement are the Placement Shares were issued at $0.0175 each, with participants to receive
three (3) free attaching Placement Options for every five (5) Placement Shares allotted, subject to approval of
Resolution 2.
Voting exclusion statement
The Company will disregard any votes cast in favour on Resolution 1 by or on behalf of any person who participated in the
Placement and any person associated with those persons.
However, this does not apply to a vote cast in favour of a resolution by:
(i) a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with directions
given to the proxy or attorney to vote on the resolution in that way; or
(ii) the chair of the meeting as proxy or attorney for a person who is entitled to vote on the resolution, in accordance
with a direction given to the chair to vote on the resolution as the chair decides; or
(iii) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary
provided the following conditions are met:
• the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting,
and is not an associate of a person that is excluded from voting, on the resolution; and
• the holder votes on the resolution in accordance with directions given by the beneficiary to the holder to
vote in that way.
Directors’ Recommendation
The Directors consider that the ratification of the Placement Shares is beneficial for the Company as it allows the Company to
retain the flexibility to issue further securities representing up to 25% of the Company’s share capital during the next 12
months.
The Directors unanimously recommend that Shareholders vote in favour of Resolution 1. The Chair intends to vote undirected
proxies in favour of Resolution 1.
Resolution 2 – Approval of Issue of Placement Options
Background
As noted above, on 17 October 2025, the Company announced a $13million Placement to institutional and
professional/sophisticated investors followed by a SPP to raise funds to progress the Great White Project, the HPA project
and for general working capital (including costs of the capital raise).
On 24 October 2025 the Company completed the Placement issuing the 742,857,1435 Placement Shares.
For every 5 Placement Shares applied for, the Placement participants are entitled to 3 attaching Placement Options, subject
to Shareholder approval.
The purpose of Resolution 2 is to seek Shareholder approval the issue of the Placement Options pursuant to Listing Rule 7.1.
Regulatory Requirements
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of equity securities that a listed
company can issue without approval of its shareholders over any 12-month period to 15% of the fully-paid ordinary securities
it had on issue at the start of that period.
The Placement Options did not fit within any of the exceptions to Listing Rule 7.1 and exceeds the 15% limit in Listing Rule
7.1. It therefore requires the approval of Shareholders under Listing Rules 7.1
Resolution 2 seeks the required Shareholder approval to the issue of the Placement Options under and for the purposes of
Listing Rule 7.1.
If Resolution 2 is passed, the Company will be able to proceed with the issue of the Placement Options and Placement
participants will receive their free attaching Placement Options. In addition the issue of the Placement Options will be
excluded from the calculation of the number of equity securities that the Company can issued without Shareholder approval
under Listing Rule 7.1.
Page | 7
If Resolution 2 is not passed, the Company will not be able to proceed with the issue of the Placement Options and Placement
participants will not receive their free attaching Placement Options.
Listing Rules Information Requirements
In accordance with the requirements of Listing Rule 7.3, the following information is provided in relation to Resolution 2:
(a) The Placement Options will be issued to the various institutional and professional/sophisticated investors that
participated in the Placement (being investors identified by the Joint Lead Managers or existing Shareholders and
excluding any related parties, members of Key Management Personnel, substantial Shareholders or advisers).
(b) 458,714,286 Placement Options are to be issued in total.
(c) The Placement Options are each exercisable for one Share at $0.026 and expire 2 years after the date of issue. Full
terms and conditions are set out in Annexure 1 to this Explanatory Memorandum.
(d) If Resolution 2 is approved, the Company intends to issue the Placement Options on or about 11 December 2025 and
in any case within 3 months from the date of the Meeting.
(e) The Placement Options are free attaching Options to the Placement Shares (with Placement participants entitled to
three (3) Placement Options for every five (5) Placement Shares allotted subject to approval of Resolution 2), with the
Placement Shares issued at $0.0175 each. The Placement Options and will be issued for nil additional consideration,
but the Company will receive $0.026 per Placement Option exercised.
(f) The Placement Options are issued in connection with the Placement (which was undertaken by the Company to
advance the Great White Project, to progress the HPA project and for costs of the capital raise and ongoing working
capital requirements).
(g) The key terms of the Placement are that each investor subscribed by one Placement Share at $0.0175, and will
receive 3 free attaching Placement Options for every 5 Shares allotted on the terms set out in Annexure 1, subject to
Resolution 2 being approved.
(h) The Placement Options are not being issued under, or to fund, a reverse takeover.
Voting exclusion statement
The Company will disregard any votes cast in favour on Resolution 2 by or on behalf of any person who is expected to
participate in, or who will obtain a material benefit as a result of, the proposed issue of the Placement Options (except a
benefit solely by reason of being the holder of ordinary securities in the Company), and person associated with those persons.
However, this does not apply to a vote cast in favour of a resolution by:
(i) a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with directions
given to the proxy or attorney to vote on the resolution in that way; or
(ii) the chair of the meeting as proxy or attorney for a person who is entitled to vote on the resolution, in accordance
with a direction given to the chair to vote on the resolution as the chair decides; or
(iii) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary
provided the following conditions are met:
• the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting,
and is not an associate of a person that is excluded from voting, on the resolution; and
• the holder votes on the resolution in accordance with directions given by the beneficiary to the holder to
vote in that way.
Directors’ Recommendation
The Directors consider that the approval of the Placement Options is beneficial for the Company as it allows the Placement
participants to receive their free attaching Placement Options, the exercise of which may provide up to approximately $11.6
million additional working capital to the Company.
The Directors unanimously recommend that Shareholders vote in favour of Resolution 2. The Chair intends to vote undirected
proxies in favour of Resolution 2.
Resolution 3 – Approval of Issue of SPP Options
Background
Page | 8
As noted above, on 17 October 2025, the Company announced a $13million Placement to institutional and
professional/sophisticated investors followed by a SPP on the same terms to raise funds to progress the Great White Project,
the HPA project and for general working capital (including costs of the capital raise).
On 27 October 2025 the Company opened the SPP, with the closing date at 14 November 2025. Whilst the SPP is targeting
an amount of $2.5 million, the Board has the discretion to accept more than this and, theoretically, a total of up to
1,145,002,922 New Shares could be applied for by Shareholders under the limits in the Listing Rules. The SPP will close on or
about 14 November, with the Shares to be issued under the SPP on or about 21 November 2025, unless extended.
For every 5 SPP Shares applied for, the SPP participants are entitled to 3 free attaching SPP Options, subject to Shareholder
approval.
The purpose of Resolution 3 is to seek Shareholder approval the issue of the SPP Options pursuant to Listing Rule 7.1.
Regulatory Requirements
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of equity securities that a listed
company can issue without approval of its shareholders over any 12-month period to 15% of the fully-paid ordinary securities
it had on issue at the start of that period.
The SPP Options did not fit within any of the exceptions to Listing Rule 7.1 and exceeds the 15% limit in Listing Rule 7.1. It
therefore requires the approval of Shareholders under Listing Rules 7.1
Resolution 3 seeks the required Shareholder approval to the issue of the SPP Options under and for the purposes of Listing
Rule 7.1.
If Resolution 3 is passed, the Company will be able to proceed with the issue of the SPP Options and SPP participants will
receive their free attaching SPP Options. In addition the issue of the SPP Options will be excluded from the calculation of the
number of equity securities that the Company can issued without Shareholder approval under Listing Rule 7.1.
If Resolution 3 is not passed, the Company will not be able to proceed with the issue of the SPP Options and SPP participants
will not receive their free attaching SPP Options.
Listing Rules Information Requirements
In accordance with the requirements of Listing Rule 7.3, the following information is provided in relation to Resolution 3:
(a) The SPP Options will be issued to the eligible shareholders that participate in the SPP. Ms Sue-Ann Higgins, who is a
related party by virtue of being a Director of the Company, participated in the SPP. Further details regarding Ms
Higgin's participation is provided in connection with Resolution 6 below.
(b) Up to 687,001,753 SPP Options may be issued in total (based on the maximum take up permitted for the SPP under
the Listing Rules)
(c) The SPP Options are each exercisable for one Share at $0.026 and expire 2 years after the date of issue. Full terms
and conditions are set out in Annexure 1 to this Explanatory Memorandum.
(d) If Resolution 3 is approved, the Company intends to issue the SPP Options on or about 11 December 2025 and in any
case within 3 months from the date of the Meeting.
(e) The SPP Options are free attaching Options to the SPP Shares (with SPP participants entitled to three (3) SPP Options
for every five (5) SPP Shares allotted subject to approval of Resolution 3), with the SPP Shares issued at $0.0175 each.
The SPP Options and will be issued for nil additional consideration, but the Company will receive $0.026 per SPP
Option exercised.
(f) The SPP Options are issued in connection with the SPP (which was undertaken by the Company to advance the Great
White Project, to progress the HPA project and for costs of the capital raise and ongoing working capital
requirements).
(g) The key terms of the SPP are that each investor subscribed for SPP Shares at $0.0175 per Share, and will receive 3
free attaching SPP Options for every 5 Shares allotted on the terms set out in Annexure 1, subject to Resolution 3
being approved.
(h) The SPP Options are not being issued under, or to fund, a reverse takeover.
Voting exclusion statement
The Company will disregard any votes cast in favour on Resolution 3 by or on behalf of any person who is expected to
participate in, or who will obtain a material benefit as a result of, the proposed issue of the SPP Options (except a benefit
solely by reason of being the holder of ordinary securities in the Company), and person associated with those persons.
However, this does not apply to a vote cast in favour of a resolution by:
Page | 9
(i) a person as
Share your feedback
Discover